Whan In Pharm Co.,Ltd.

KSE 016580.KS

Whan In Pharm Co.,Ltd. Gross Profit Margin for the year ending December 31, 2023: 42.59%

Whan In Pharm Co.,Ltd. Gross Profit Margin is 42.59% for the year ending December 31, 2023, a -14.24% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Whan In Pharm Co.,Ltd. Gross Profit Margin for the year ending December 31, 2022 was 49.66%, a -5.57% change year over year.
Whan In Pharm Co.,Ltd. Gross Profit Margin for the year ending December 31, 2021 was 52.59%, a 4.27% change year over year.
Whan In Pharm Co.,Ltd. Gross Profit Margin for the year ending December 31, 2020 was 50.44%, a 1.39% change year over year.
Whan In Pharm Co.,Ltd. Gross Profit Margin for the year ending December 31, 2019 was 49.74%, a -2.98% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

KSE: 016580.KS

Whan In Pharm Co.,Ltd.

CEO	Mr. Wonbum Lee
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	Whanin Building, 11
Employees	582
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Whan In Pharm Co.,Ltd., a pharmaceutical company, develops, manufactures, markets, and sells therapeutic products in South Korea. It offers anti-depressants, anti-psychotics, nootropics and anti-dementia, anti-epileptics, cardiovascular, gastrointestinal, antibiotics, antiviral agents, antihistamines, anti-inflammatory and analgesics, metabolic disorders, respiratory, central nervous system, other drug products. The company was founded in 1978 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years